Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by joezhangon Sep 26, 2018 5:47pm
223 Views
Post# 28696715

News links

News links

Dual Listing to Broaden Scope of Would-Be Pot Investors

In an interview with the Financial Post on Tuesday, Aurora's Chief Corporate Officer Cam Battley indicated that the dual-listing would help broaden the scope of Aurora's would-be investors, which he said includes "U.S. institutional investors, not all of whom are able to trade in OTC-listed securities." 

The Toronto-listed stock is currently available for purchase as an over the counter (OTC) market ticker which allows US investors to purchase shares in foreign-listed companies. 

Battley told the Post that the weed producer will "look at all exchanges," and that it will look at the New York Stock Exchange (NYSE). He added that there may be additional information available after Aurora posts earnings next week. 

On Wednesday, Robinhood, a zero-fee brokerage platform popular among Millennial investors, suspended new buying of Aurora Cannabis due to heightened demand for the stock. "This is happening because there's limited support at execution venues for the large volume of ACBFF orders we've received," Robinhood told users, according to Business Insider.  

Aurora's dual listing would follow suit of fellow Canadian cannabis companies Tilray Inc. (TLRY) and Canopy Growth Corp. (CGC), which have sharply outperformed the broader market after their U.S. public offerings. 

Earlier this week, BNN Bloomberg first reported that beverage giant Coca Cola Co. (KO) was in talks with Aurora to develop a drink infused with CBD, the non-psychoactive ingredient in marijuana that treats pain



Read more: Aurora Cannabis Contemplating U.S. Stock Listing | Investopedia https://www.investopedia.com/news/aurora-cannabis-contemplating-us-stock-listing/#ixzz5SFMqnknv 
Follow us: Investopedia on Facebook
Bullboard Posts